The Efficacy and Safety of PRTX007-003 Combined With Pembrolizumab in Resectable Stage III Melanoma
The Efficacy and Safety of PRTX007-003 Combined With Pembrolizumab in Resectable Stage III Melanoma
Recruiting · NCT07565285 · Registry updated 2026-08-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Efficacy and Safety of PRTX007-003 Combined With Pembrolizumab in Resectable Stage III Melanoma | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Recruiting | Phase 2 | 2026-08-19 | NCT07565285 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Primmune Therapeutics, Inc. | 1 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cairns And Hinterland Hospital And Health Service | Cairns | Australia | 2 |
| Calvary Mater Newcastle | Waratah | Australia | 49 |
| Gallipoli Medical Research | Greenslopes | Australia | 1 |
| One Clinical Research Pty Ltd | Nedlands | Australia | 3 |
| Peter MacCallum Cancer Centre | Melbourne | Australia | 149 |
| Princess Alexandra Hospital | Woolloongabba | Australia | 106 |
| Sir Charles Gairdner Hospital | Nedlands | Australia | 43 |